Simplified Our GIP/GLP-1 Studies
The dual incretin agonist activity was confirmed in our bioassays. Having tirzepatide in a pre-mixed pen has removed the single biggest bottleneck from our research protocol. ORYN has earned a long-term customer.
PopularDual Incretin Research Peptide · 3-5-Day Delivery to Castellon
A dual GIP/GLP-1 receptor agonist extensively studied in metabolic research. Clinical trials suggest Tirzepatide may modulate appetite signalling and glucose homeostasis through dual incretin pathways. ORYN Tirzepatide pen delivers 20mg/3ml in a reusable system with precision dosing for 30 days.
Tirzepatide is a novel dual incretin agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Clinical trials suggest this dual action may provide enhanced metabolic research outcomes compared to GLP-1-only agonists.
LEGAL & REGULATORY
Los peptidos de investigacion se pueden adquirir legalmente en Espana con fines cientificos. Bajo la Ley de Garantias y Uso Racional de los Medicamentos, los peptidos vendidos exclusivamente para investigacion no se consideran medicamentos autorizados y no requieren receta medica.
Full Spain legal guide →LOCAL PRICING
From £139 UK · €169 EU · $179 US · R$ 849 BR. All prices include customs and shipping within the destination region, no hidden fees at the door.
RESEARCH FOCUS
Tirzepatide represents a paradigm shift in metabolic peptide science as the first dual GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist. By activating both incretin pathways simultaneously, it produces metabolic effects that exceed what either pathway achieves alone. At the GLP-1 receptor, tirzepatide slows gastric emptying, suppresses glucagon secretion, enhances glucose-dependent insulin release, and activates satiety centres in the hypot…
DISPATCH & DELIVERY
Canary Islands delivery available but may require 5–7 days.
VERIFIED REVIEWS
The dual incretin agonist activity was confirmed in our bioassays. Having tirzepatide in a pre-mixed pen has removed the single biggest bottleneck from our research protocol. ORYN has earned a long-term customer.
Finally a European source for properly formulated tirzepatide in a pen system. Purity is verified, the dosing mechanism is precise, and delivery to the Netherlands was just four days.
The dual GIP/GLP-1 agonist formulation is spot-on. We've run three independent assays and every result aligns with the COA. Packaging, delivery, and product quality are all first class.
ORYN delivers Tirzepatide peptide pens directly to Castellon, Spain with 3-5-day tracked delivery. Order online and receive your pre-mixed, research-grade pen at your door.
ORYN Tirzepatide is priced at €169 per pen, containing a 30-day supply of 20 mg in a pre-mixed, ready-to-use pen system. Free delivery on qualifying orders.
ORYN ships same-day for orders placed before 3 PM with 3-5-day delivery to Castellon. All orders ship in discreet, temperature-controlled packaging.
ORYN Tirzepatide exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
3-5-day tracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER TIRZEPATIDE — €169